Skip to main content
Premium Trial:

Request an Annual Quote

SeraCare Acquires Reagents and Antibodies Supplier KPL

NEW YORK (GenomeWeb News) – SeraCare Life Sciences today said that it has acquired Kirkegaard & Perry Laboratories, a supplier of antibodies and reagents for the life science research and diagnostics markets.

Among the products offered by Gaithersburg, Md.-based KPL are reagents kits for protein labeling and purification, nucleic acid labeling, sample preparation, western blotting, immunohistology, and ELISAs. Milford, Mass.-based SeraCare said that the acquisition will expand its portfolio of products and control materials for infectious disease, women's health, and genetic testing in oncology, autoimmune, allergy, and companion diagnostics.

Financial terms of the acquisition were not disclosed, and SeraCare didn't provide revenue figures for privately held KPL.

SeraCare said that it received funding for the acquisition and refinanced existing debt with Mason Capital Funding and BB&T Capital Partners.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.